Apolipoprotein (a) mediates the lipoprotein (a)-induced biphasic shift in human platelet cyclic AMP

Thrombosis Research

Volumn 112, Issue 5-6, 2003, Pages 321-324

  Barre, D E ^a  

^a CAPE BRETON UNIVERSITY   (Canada)

Author keywords

Apo(a); c AMP; Lp(a)

Indexed keywords

ANTIBODY; APOLIPOPROTEIN; COLLAGEN; CYCLIC AMP; LIPOPROTEIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPOSURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PURIFICATION; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION;

EID: 1642377928     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.01.002     Document Type: Article

References (25)

1. Hassall D.G., Owen J.S., Bruckdorfer K.R. The aggregation of human platelets in the presence of lipoproteins and prostacyclin. Biochem. J. 216:1983;43-49.
2. Korporaal S.J., Relou I.A., van Rijn H.J., Akkerman J.W. Lysophosphatidic acid-independent platelet activation by low-density lipoprotein. FEBS Lett. 494:2001;121-124.
3. Saniabadi A.R., Umemura K., Suzuki Y., Kondo K., Ikeda Y., Adachi M.et al. Adenosine 5′-diphosphate as a factor in platelet aggregation induced by human plasma remnant lipoproteins. Life Sci. 63:1998;1065-1074.
4. 3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate. Arterioscler. Thromb. Vasc. Biol. 18:1998;861-869.
5. Bruckdorfer K.R., Buckley S., Hassall D.G. The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets. Biochem. J. 223:1984;189-196.
6. Gries A., Gries M., Wurm H., Kenner T., Ijsseldijk M., Sixma J.J.et al. Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes. Arterioscler. Thromb. Vasc. Biol. 16:1996;648-655.
7. IIbβ3(GPIIb-IIIa) is not implicated in the binding of LDL to intact resting platelets. Arterioscler. Thromb. Vasc. Biol. 17:1997;156-163.
8. Rand M.L., Sangrar W., Hancock M.A., Taylor D.M., Marcovina S.M., Packham M.A.et al. Apolipoprotein(a) enhances platelet responses to the thrombin receptor-activating peptide SFLLRN. Arterioscler. Thromb. Vasc. Biol. 18:1998;1393-1399.
9. Martinez C., Rivera J., Loyau S., Corral J., Gonzalez-Conejero R., Lozano M.L.et al. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation. Thromb. Haemost. 85:2001;686-693.
10. Malle E., Ibovnik A., Leis H.J., Kostner G.M., Verhallen P.F.J., Sattler W. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation. Arterioscler. Thromb. Vasc. Biol. 15:1995;377-384.
11. Seman L.J., de Luca C., Jenner J.L. Isolation and purification of serum lipoprotein (a) using lectin affinity. Methods Mol. Biol. 110:1998;131-136.
12. Armstrong V.W., Wall A.K., Seidel D. Isolation, characterization and uptake in human fibroblasts of an apo (a)-free lipoprotein obtained on reduction of lipoprotein(a). J. Lipid Res. 26:1985;1314-1323.
13. Gaubatz J.W., Heideman C., Gotto A.M., Morrisett J.D., Dahlen G.H. Human plasma lipoprotein(a): structural properties. J. Biol. Chem. 258:1983;4582-4589.
14. Laurell C.-B. Quantitative estimation of proteins by electrophoreses in agarose gel containing antibodies. Anal. Biochem. 15:1966;45-52.
15. Utermann G., Menzel H.J., Kraft H.G., Duba H.C., Kemmler H.G., Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J. Clin. Invest. 80:1987;458-465.
16. Aster R.H., Jandl J.H. Platelet sequestration in man: I. Methods. J. Clin. Invest. 43:1964;843-855.
17. Mustard J.F., Perry D.W., Ardlie N.G., Packham M.A. Preparation of suspensions of washed platelets from humans. Br. J. Haematol. 22:1972;193-204.
18. Barre D.E. Apoprotein (a) antagonises the GPIIB/IIIA receptor on collagen- and ADP-stimulated human platelets. Front. Biosci. 9:2004;404-410.
19. Farndale R.W., Winkler A.B., Martin B.R., Barnes M.J. Inhibition of human platelet adenyl cyclase by collagen fibrils. Biochem. J. 282:1992;25-32.
20. 2. Prostaglandins. 13:1977;599-609.
21. 1. J. Cardiovasc. Pharmacol. 25:1995;961-966.
22. Colli S., Maderna P., Tremoli E., Baraldi A., Rovati G.E., Gianfranechi G., Nicosia S. Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase. Biochem. Pharmacol. 34:1985;2451-2457.
23. Jang E.K., Azzam J.E., Dickinson N.T., Davidson M.M.L., Haslam R.J. Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen induced platelet aggregation by nitroprusside. Br. J. Haematol. 117:2002;664-675.
24. Malle E., Ibovnik A., Steinmetz A., Kostner G.M., Sattler W. Identification of glycoprotein IIb as the Lp(a) binding protein on platelets. Arterioscler. Thromb. Vasc. Biol. 14:1994;345-352.
25. 2 production. Platelets. 9:1998;93-96.